Published Technical Disclosure Archive

Venglustat-based Solutions for Diverse Industries

Publication ID: 24-11857512_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Venglustat-based Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857512_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857512_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,512.

Summary of the Inventive Concept

The inventive concept expands the application of venglustat beyond pharmaceutical compositions to address various challenges in agriculture, wastewater treatment, 3D printing, environmental monitoring, and food preservation.

Background and Problem Solved

The original patent disclosed pharmaceutical compositions comprising venglustat for treating diseases. However, the core technology of venglustat has untapped potential in other industries. This inventive concept addresses the limitations of the original patent by exploring novel applications and use cases for venglustat, thereby opening up new avenues for innovation and problem-solving.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for agricultural pest control, wherein venglustat inhibits the growth of certain fungal species that contribute to plant disease. Additionally, venglustat can be used in methods for treating wastewater by breaking down complex organic compounds, and in compositions for 3D printing to modify the physical properties of the printed material. Furthermore, venglustat can be employed in systems for detecting and quantifying environmental pollutants as a sensing agent, and in methods for preserving food products by inhibiting the growth of microorganisms that cause spoilage.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of venglustat, transitioning from pharmaceutical compositions to diverse industries. The inventive step lies in recognizing the potential of venglustat to address specific challenges in these new fields, thereby creating novel solutions that are non-obvious and unexpected.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using venglustat in combination with other compounds or agents to enhance its effectiveness in these new applications. Variations of the inventive concept could involve modifying the structure or formulation of venglustat to optimize its performance in specific industries or use cases.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, wastewater treatment, 3D printing, environmental monitoring, and food preservation. The target market includes companies and organizations operating in these industries, as well as governments and research institutions seeking innovative solutions to specific challenges.

CPC Classifications

SectionClassGroup
A A61 A61K31/439
A A61 A61K9/0053
A A61 A61K9/2009
A A61 A61K9/2013
A A61 A61K9/2018
A A61 A61K9/2095
A A61 A61K9/485
A A61 A61K9/4833
A A61 A61K9/4858
A A61 A61K9/4866

Field of Art

Pharmaceutical and chemical engineering, with expertise in compound modification, drug delivery systems, and interdisciplinary applications of pharmaceutical compounds across multiple technical domains

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in chemistry, pharmaceutical sciences, or chemical engineering, possessing knowledge of compound properties, interdisciplinary applications, and systematic approaches to exploring novel uses of known chemical entities

Obviousness Rationale

A PHOSITA would recognize that venglustat's fundamental molecular properties enable its extension beyond pharmaceutical applications through predictable modifications. The source patent establishes venglustat's core chemical characteristics, which inherently suggest potential for broader applications in related technical domains. The disclosed variations represent logical extrapolations of the compound's known inhibitory and interactive properties across different technological contexts.

Obvious Combinations & Variations

Source Patent Element
Venglustat as a pharmaceutical compound with enzyme inhibition capabilities
PTD Variation
Agricultural pest control by inhibiting fungal species growth
Obviousness Reasoning
A PHOSITA would recognize that enzyme inhibition mechanisms are transferable across biological systems, making fungal growth inhibition a predictable extension of the compound's known pharmacological properties
Source Patent Element
Pharmaceutical formulation techniques involving compound interactions
PTD Variation
Wastewater treatment through organic compound breakdown
Obviousness Reasoning
The source patent's teachings about compound interactions and chemical transformations would suggest to a PHOSITA that venglustat could be applied to breaking down complex organic structures in alternative environmental contexts
Source Patent Element
Tablet and dosage form manufacturing processes
PTD Variation
3D printing composition modification using venglustat
Obviousness Reasoning
A PHOSITA would understand that materials science frequently adapts pharmaceutical formulation techniques, making the use of venglustat as a material property modifier a logical design choice
Source Patent Element
Pharmaceutical compound with specific molecular interaction capabilities
PTD Variation
Environmental pollutant detection using venglustat as a sensing agent
Obviousness Reasoning
The compound's established ability to interact with specific molecular structures naturally suggests its potential as a sensing mechanism in environmental monitoring applications
Source Patent Element
Antimicrobial properties inherent in pharmaceutical compounds
PTD Variation
Food preservation through microbial growth inhibition
Obviousness Reasoning
A PHOSITA would recognize that compounds with antimicrobial characteristics can be systematically applied across preservation contexts, making food product preservation a predictable extension of the compound's known properties
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed herein would have been obvious to a person having ordinary skill in the art at the time of invention, as evidenced by US Patent 11857512 and the accompanying Published Technical Disclosure. The systematic exploration of venglustat's fundamental chemical properties across diverse technological domains represents an obvious progression that would be readily conceived by a skilled practitioner without requiring inventive insight beyond the established scientific understanding of the compound's core characteristics.

Original Patent Information

Patent NumberUS 11,857,512
TitlePharmaceutical compositions comprising venglustat
Assignee(s)Genzyme Corporation